Tsingke leverages its mature IVT technology platform to provide advanced regulatory RNA solutions—including custom saRNA and circRNA synthesis services. These molecules do not belong to the traditional category of protein-coding RNAs. Instead, they serve as precise gene regulation tools that deeply modulate cellular functions and gene expression outcomes through mechanisms such as transcriptional activation, molecular adsorption (sponging), or structural stabilization.
| saRNA / circRNA | |||
| Product Name | Specifications | Turnaround (Business Days) | |
| Research Grade | Research Grade circRNA | 100 μg、500 μg、1 mg、2 mg、3 mg、5 mg | 7 |
| Research GradesaRNA | 100 μg、500 μg、1 mg、2 mg、3 mg、5 mg | 7 | |
| In vivo Grade | In vivo Grade saRNA | 100 μg、500 μg、1 mg、2 mg、3 mg、5 mg | 7~10 |
| In vivo Grade circRNA | 100 μg、500 μg、1 mg、2 mg、3 mg、5 mg | 10~12 | |
| LNP Encapsulation | LNP Encapsulation | 100 μg、500 μg、1 mg、2 mg、3 mg、5 mg | 2~3 |
circRNA Design: Optimized introns, exons, CDS, and IRES.
circRNA Design: Optimized introns, exons, CDS, and IRES.
circRNA Production: Plasmid construction and circularization (>80% efficiency).
circRNA Production: Plasmid construction and circularization (>80% efficiency).
circRNA Purification: Multiple methods for >95% purity.
circRNA Purification: Multiple methods for >95% purity.
LNP Encapsulation: Customized lipid nanoparticles.
LNP Encapsulation: Customized lipid nanoparticles.
Quality Control: Circular ratio and purity analyses.
Quality Control: Circular ratio and purity analyses.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
